home / stock / dmttf / dmttf articles

DMTTF Articles, Small Pharma - From 10/13/23

Stock Information
Company Name: Small Pharma
Stock Symbol: DMTTF
Market: OTC
Website: smallpharma.com
Menu
DMTTF DMTTF Quote DMTTF Short DMTTF News DMTTF Articles DMTTF Message Board
Get DMTTF Alerts

News, Short Squeeze, Breakout and More Instantly...
Cybin And Small Pharma Shareholders Green Light Acquisition Resolution: Results & Expected Dates | Benzinga

Clinical-stage psychedelics biotechs Canada-based Cybin Inc. (NYSE: CYBN) and UK-based Small Pharma Inc. (OTCQB: DMTTF) held their respective annua...
Psyched: DMT & SSRIs For Depression, MDMA Training, Negative Responses To Psychedelics & More | Benzinga

Depression Relief: Possible Therapy Boost With DMT & SSRIs Small Pharma Clinical Results New findings on safety, tolerability and efficacy...

Depression Relief: Possible Therapy Boost With DMT & SSRIs, Per Small Pharma Clinical Results | Benzinga

New findings on safety, tolerability and efficacy from a clinical study assessing the interaction of psychedelics and traditional pharma for the tr...

Psyched: Steve Cohen Goes Big On Cybin, Fed Intervention On Psilocybin, Ketamine Insurance And More | Benzinga

Billionaire Steve Cohen Buys 19M Shares Of Cybin Stock For Psychedelics R&D, Blake Mycoskie $100M Pledge Billionaire hedge fund and NY Mets own...
Cybin Delivers Highest Dose Of Psilocybin Analog In Phase 2 For Major Depression | Benzinga

Clinical-stage psychedelics biotech Cybin (NYSE: CYBN) has completed enrollment in its Phase 2 study of novel deuterated psilocybin analog CYB003 f...

Billionaire Steve Cohen Invests $19M In Cybin For Psychedelics R&D, Blake Mycoskie's $100M Pledge Update | Benzinga

Billionaire hedge fund and NY Mets owner, Steve Cohen amped up his support for psychedelics R&D through a new investment of nearly $1...

Cybin's Intellectual Powerhouse Grows With New US Patent Covering Deuterated 5-MeO-DMT | Benzinga

The U.S. Patent and Trademark Office (USPTO) has granted Canada-based psychedelics company Cybin Inc. (NYSE: CYBN) a new patent covering the c...
Psyched: Three Noteworthy Psychedelics M&As, Colorado's Regulations, Exclusive Financing & More | Benzinga

Cybin's Acquisition Of Small Pharma Will Elevate DMT Therapeutics For Depression And Anxiety Psychedelics biotech Cybin (NYSE: CYBN) and UK-bas...

Mindset Pharma's $60M Acquisition, Otsuka's Leap Into Next-Gen Psychiatry Solutions | Benzinga

Canadian next-generation psychedelics developer Mindset Pharma (OTCMKTS: MSSTF) has entered into a definitive agreement to acquire all ou...

Second Psychedelics Merger Of The Week? Silo Wellness To Buy Jamaica-Based Business For $31.9M | Benzinga

Silo Wellness (OTCQB: SILFF) has confirmed its intention to acquire all issued and outstanding securities of NUGL Inc./Kaya Group (OTC Pink: N...
Previous 10 Next 10